- About
- Organization
- Organization Overview
- Dean’s Office
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Research
- Education
- Patient Care
- People
- News
- Events
Fischbach receives young investigator grant for probiotics research
By UCSF School of Pharmacy Editorial Staff / Fri Aug 6, 2010
Michael Fischbach, PhD
Michael Fischbach, PhD, a faculty member in UCSF’s Department of Bioengineering and Therapeutic Sciences, is one of two recipients of the 2010 Young Investigator Grant for Probiotics Research. The announcement was made August 2, 2010, by The Global Products Council, which funds the program to contribute to the advancement of probiotics and gastrointestinal microbiota research in the United States. Fischbach's research project is entitled “A Gene-to-Model Approach to Discovering New Antibiotics from Probiotic Bacteria.”
More
Tags
Topics:
Category:
Sites:
School of Pharmacy, Department of Bioengineering and Therapeutic Sciences, PharmD Degree Program, BMI, QBC, CCB, PSPG, Bioinformatics
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.
